Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Allogene Therapeutics, Inc.
About ALLO
Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is focused on development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. It is focused on three core programs: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID), and Renal Cell Carcinoma (RCC). It is developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein engineering, gene editing, gene insertion and advanced proprietary T cell manufacturing technologies. Its product candidate, cemacabtagene ansegedleucel, referred to as cema-cel, is an engineered allogeneic CAR T cell product candidate that targets CD19, a protein expressed on the cell surface of B cells and a validated target for B cell driven hematological malignancies. It is focused on developing cema-cel for LBCL. Its pipeline also includes ALLO-316 and ALLO-329.
Find out what a historical investment in Allogene Therapeutics, Inc. would be worth today using our ALLO stock calculator.
Market Capitalisation
$690.31M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
7.67M
High today
$2.19
Low today
$1.97
Open price
$2.12
52-week high
$4.46
52-week low
$0.94
Ready to start your investing journey with Stake?
Open an accountHow do I buy ALLO shares in Australia?
Buying ALLO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Allogene Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ALLO
What is the ticker symbol of Allogene Therapeutics, Inc.?
The ticker symbol for Allogene Therapeutics, Inc. is ALLO.
How much is one share of ALLO?
One share of ALLO is valued at $2.00 as of 16 May 2026.
What is the market capitalisation of Allogene Therapeutics, Inc. ALLO?
As of 16 May 2026 Allogene Therapeutics, Inc. has a market cap of $690.31M.
What is the 52-week high for Allogene Therapeutics, Inc. stock?
The Allogene Therapeutics, Inc. 52-week high stock price is $4.46.
What is the 52-week low for Allogene Therapeutics, Inc. stock?
The Allogene Therapeutics, Inc. 52-week low stock price is $0.94.
Can I buy ALLO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ALLO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ALLO on Stake
- Buy ALLO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ALLO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ALLO related stocks